Announcement on the Purchase of Ammonium Ferric Citrate Raw Material Medicine


Time:

2016-01-04

Our company purchased ferric ammonium citrate raw material (approval number: Chinese medicine standard H20093152) from Chongqing Quanxin Xiangsheng Biopharmaceutical Co., Ltd. in March 2015. The batch number of the raw material is C03150105 kg, totaling 20kg. This batch of raw materials used to produce 16 batches of compound Pseudostellaria heterophylla granules and 1 batch of compound Pseudostellaria heterophylla oral liquid, with 19.22252kg in stock, have been returned according to the company's requirements. Compound Pseudostellaria oral liquid belongs to the dosage form of this year's license addition, which is not yet on the market. There are 105 batches of compound Pseudostellaria heterophylla granules in the effective period (production time: January 1, 2014-December 31, 2015), and the product is sold nationwide. According to the notice received from the drug administration department on December 30, 2015: "Notice on Risks of Ferric Ammonium Citrate Products of Chongqing Quanxin Xiangsheng Biopharmaceutical Co., Ltd." (No. 111 of 2015). The enterprise has initiated the recall procedure and stopped selling and sealing the finished and intermediate products in stock.

is hereby announced

Fujian Mindong Lijiexun Pharmaceutical Co., Ltd.

January 4, 2016